baber/WOPTO huggingface dataset:
Patent CA-2529942-A1 (CA)
Inventor: POPESCU GABRIEL
IPC: G01N21/45
Filed: 2004-06-18
Abstract: Preferred embodiments of the present invention are directed to systems for phase measurement which address the problem of phase noise using combinations of a number of strategies including, but not limited to, common-path interferometry, phase referencing, active stabilization and differential measurement. Embodiment are directed to optical devices for imaging small biological objects with light. These embodiments can be applied to the fields of, for example, cellular physiology and neuroscience. These preferred embodiments are based on principles of phase measurements and imaging technologies. The scientific motivation for using phase measurements and imaging technologies is derived from, for example, cellular biology at the sub-micron level which can include, without limitation, imaging origins of dysplasia, cellular communication, neuronal transmission and implementation of the genetic code. The structure and dynamics of sub-cellular constituents cannot be currently studied in their native state using the existing methods and technologies including, for example, x-ray and neutron scattering. In contrast, light based techniques with nanometer resolution enable the cellular machinery to be studied in its native state. Thus, preferred embodiments of the present invention include systems based on principles of interferometry and/or phase measurements and are used to study cellular physiology. These systems include principles of low coherence interferometry (LCI) using optical interferometers to measure phase, or light scattering spectroscopy (LSS) wherein interference within the cellular components themselves is used, or in the alternative the principles of LCI and LSS can be combined to result in systems of the present invention
Patent CA-2530392-A1 (CA)
Inventor: LIPTROT MICHAEL C
IPC: A01M1/20
Filed: 2004-06-25
Abstract: Dispensers and refills for volatile liquids, such as fragrances, are disclosed. Dispensers and refills (20) in combination with dispensers according to the present invention may comprise a volatile liquid and a housing (30). In certain embodiments, the volatile liquid of the present invention has a predetermined evaporation rate, measured and calculated by the method described herein. In other embodiments, the volatile liquid exhibits a predefined relative evaporation rate. In addition to the housing, the present invention includes optional components, such as a motorized (32) fan and/or a wick (31), to facilitate release of the volatile liquid into the atmosphere.
Patent CA-2532047-A1 (CA)
Title: System, device & method for applying cos policies
Inventor: TUFAIL MUDASSIR
IPC: H04L69/14
Filed: 2006-01-05
Abstract: Certain exemplary embodiments comprise a method, comprising: in a BGP network comprising a plurality of neighbors: associating a desired COS policy for a specified interface with a BGP community value; and providing a BGP update message comprising the BGP community value.
Patent CA-2532360-A1 (CA)
Title: Compositions related to a novel endophytic fungi and methods of use
Inventor: JIMENEZ JORGE
IPC: A01N63/30
Filed: 2004-07-16
Abstract: This invention provides pesticidally effective compositions related to a novel endophytic fungi named Muscodor. Specifically, the invention relates to commercially useful formulations of Muscodor and methods for preparing such formulations. It also provides various synthetic pesticidal mixtures of volatile organic compounds isolatable from Muscodor grown on various substrates. Also provided are methods for inhibiting the growth of organisms, such as microbes, insects, and nematodes by exposing such organisms or the habitats thereof to the above Muscodor-related compositions.
Patent CA-2533421-A1 (CA)
Inventor: LAMBERT LEWIS H JR
IPC: A61K38/08
Filed: 2004-07-23
Abstract: The present invention provides novel the use of materials including XMP.629 for treating acne, and including methods comprising administering to a subject a composition comprising a therapeutically effective amount of XMP.629 or a pharmaceutically acceptable salt or derivative thereof.
Patent CA-2533823-A1 (CA)
Inventor: GREEN BRENT E
IPC: A23J3/14
Filed: 2004-07-30
Abstract: Flax protein isolates are obtained in a procedure in which flax oil seeds are initially extracted to remove mucilage therefrom prior to crushing to recover the oil and produce a meal. The flax protein meal then is processed to recover a flax protein isolate therefrom.
Patent CA-2534181-A1 (CA)
Title: Steering device for steering wheels
Inventor: GAETANI ANGELO
IPC: B62D7/02
Filed: 2004-08-02
Abstract: A steering apparatus for steering wheels (1) of a vehicle (2) comprises support means (4) arranged for supporting said wheels (1), driving means (27) arranged for rotating said support means (4) around respective longitudinal axis means (Z) and connecting means arranged for connecting said driving means (27) with said support means (4), said connecting means comprising transmission gear means (26); a vehicle comprises steered wheel means (1) and steering means (3) arranged for controlling said steered wheel means (1), said steering means (3) comprising support means (4) arranged for supporting said steered wheel means (1), driving means (27) arranged for rotating said support means (4) around respective longitudinal axis means (Z) and connecting means arranged for connecting said driving means (27) with said support means (4), said connecting means comprising transmission gear means (26).
Patent CA-2535406-A1 (CA)
Title: Gabanergic modulators
Inventor: LIN XIAO-FA
IPC: C07D471/02
Filed: 2004-08-05
Abstract: This invention relates to the use of compounds of benzoindazole derivatives salts and solvates thereof for the preparation of a medicament for modulating alpha2 subtype GABA A receptors. The invention further relates to novel heterocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the use of compounds of formula (I) salts and solvates thereof for the preparation of a medicament for the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.
Patent CA-2535682-A1 (CA)
Title: Alignment mechanism for a welding torch
Inventor: GIESE WILLIAM R
IPC: B23K9/16
Filed: 2006-02-08
Abstract: In accordance with one exemplary embodiment, the present invention provides a welding torch that includes features facilitating aligned assembly of various components of the welding torch with respect to one another. For example, the welding torch includes a nipple that carries a pin member extending from both an inner peripheral surface and an outer peripheral of a sleeve of the nipple.  This pin engages with a slot on a coupling member and a slot on a neck assembly, thereby facilitating proper alignment of the neck assembly, coupling member, and nipple with respect to one another. Moreover, the engagement between the pin member and the slots block pivotal displacement of neck assembly, coupling member, and neck assembly with respect to one another. Advantageously, the use of a single pin member for both slots presents a more judicious construction, leading to reduced manufacturing costs, for instance.
Patent CA-2536211-A1 (CA)
Inventor: RIOS CARLOS
IPC: G06Q10/00
Filed: 2004-08-26
Abstract: A method is described for estimating sales of a particular type of item by a first entity through a first channel versus sales of the item by the first entity through a second channel includes the step of estimating a particular point of time corresponding to when the first entity initially sold the particular type of item through the first channel. The method further includes the steps of comparing data associated with sales of the particular type of item to determine an adjustment factor. Altering sales data based on the adjustment factor to obtain altered sales data, and comparing sales data of the first after the occurrence of the particular point time with the altered sales data to obtain an estimation of sales of the particular type of item by the first entity through the first channel.
Patent CA-2536238-A1 (CA)
Title: Humanization of antibodies
Inventor: WU HERREN
IPC: C07K16/00
Filed: 2004-08-18
Abstract: The present invention relates to methods of reengineering or reshaping antibodies to reduce the immunogenicity of the antibodies, while maintaining the immunospecificity of the antibodies for an antigen. In particular, the present invention provides methods of producing antibodies immunospecific for an antigen by synthesizing a combinatorial library comprising complementarity determining regions (CDRs) from a donor antibody fused in frame to framework regions from a sub-bank of framework regions. The present invention also provides antibodies produced by the methods of the invention.
Patent CA-2536800-A1 (CA)
Title: Fiber material having improved malodor scavenger properties
Inventor: WOOD WILL
IPC: D04H3/013
Filed: 2004-09-03
Abstract: The invention relates to fiber materials having improved malodor scavenger properties and a process for the manufacture of said materials. The invention especially relates to fiber materials usable in the manufacture of disposable or washable diapers, incontinent products, sanitary napkins and other such hygiene and personal care articles with improved malodor scavenger properties, and to methods of manufacturing such materials. It has been found that the incorporation of, especially nanosized, metal particles and/or a cyclodextrin material into fibers creates a "reactive" material having excellent malodor scavenging properties. More specifically, it has been found that the presence of nanosized metal or metal alloy particles and/or a cyclodextrin material in a fiber material, preferably a synthetic polymer material and more preferably a synthetic thermoplastic polymer fiber material leads to fiber materials or nonwovens having odor-controlling properties. The inventive fiber material especially is useful in the manufacture of hygienic products like disposable diapers.
Patent CA-2536861-A1 (CA)
Title: Method of forming a monolithic element including multiple conduits
Inventor: MCCLUNG CHAD A
IPC: B29C49/32
Filed: 2006-02-16
Abstract: A method of forming a pair of conduits using blow-molding techniques is disclosed. A parison is inflated and deformed to form a pair of interconnected conduits.
Patent CA-2537124-A1 (CA)
Title: Agricultural/horticultural insecticide and method for using the same
Inventor: CHIBA YUTAKA
IPC: C07C271/28
Filed: 2004-08-23
Abstract: An object of the present invention is to provide insecticides having high effectiveness. The present invention provides compounds represented by formula (1):   (see formula 1) wherein A1, A2, A3, and A4 independently represent a carbon atom, a nitrogen atom, or an oxidized nitrogen atom; R1 represents a C1-C6 alkyl group which may be substituted, a phenyl group which may be substituted, or a heterocyclic group which may be substituted; R2 and R3 independently represent a hydrogen atom, a C1-C4 alkyl group which may be substituted, or a C1-C4 alkylcarbonyl group which may be substituted; G1, G2, and G3 independently represent an oxygen atom or a sulfur atom; Xs may be the same or different and each represent a hydrogen atom, a halogen atom, a C1-C4 alkyl group which may be substituted, or an amino group which may be substituted; n represents an integer of 0 to 4; Q represents a phenyl group which may be substituted, a naphthyl group which may be substituted, a tetrahydronaphthyl group which may be substituted, or a heterocyclic group which may be substituted, insecticides containing the compounds as active ingredients, and a method for producing the compounds.     The compounds represented by formula (1) exhibit an excellent preventive effect as insecticides and also exhibit an excellent preventive effect when being combined with another insecticide, an acaricide, a nematocide, a fungicide, a herbicide, a plant growth regulator, or a biological pesticide.
Patent CA-2537336-A1 (CA)
Title: Multi-arm polymer prodrugs
Inventor: REN ZHONGXU
IPC: A61K31/765
Filed: 2004-09-17
Abstract: Provided herein are water-soluble prodrugs. The prodrugs of the invention comprise a water-soluble polymer having three or more arms, at least three of which are covalently attached to an active agent, e.g., a small molecule. The conjugates of the invention provided an optimal balance of polymer size and structure for achieving improved drug loading, since the conjugates of the invention possess three or more active agents releasably attached to a multi-armed water soluble polymer. The prodrugs of the invention are therapeutically effective, and exhibit improved properties in-vivo when compared to unmodified parent drug.
Patent CA-2537838-A1 (CA)
Title: Check valve
Inventor: MACKAL GLENN H
IPC: F16K15/02
Filed: 2004-09-08
Abstract: A check valve comprising a poppet (30) urged by a conical spring (50) to annularly seal uniformly around its entire periphery to assure more uniform cracking pressure about its entire periphery. To insure uniform sealing of the poppet (30) against a seat (36) the conical spring (50) has a smallest coil (50S) in engagement with a center protrusion (42) of the poppet (30) to permit the protrusion (42) to pivot relative to the conical spring (50).
Patent CA-2538377-A1 (CA)
Title: Polymer composition with elastomeric properties at wide temperature ranges and process for the preparation thereof
Inventor: CORONA-GALVAN SERGIO
IPC: C08L9/00
Filed: 2003-08-15
Abstract: It is depicted a polymer composition with elastomeric properties at wide temperature ranges of the type comprising polymers and/copolymers resulting from substituted or unsubstituted vinyl aromatic monomers and from dienic monomers, which is homogeneous and compatible in nature, with such composition being based on stereoregular polymers and without requiring the additional use of compatibilizing agents. Likewise, it is depicted the process to obtain the same, as well as to hydrogenise them, without requiring the use of additional catalyzers or processes.
Patent CA-2539823-A1 (CA)
Title: Hemiasterlin derivatives and uses thereof
Inventor: CAMPAGNA SILVIO A
IPC: C07D401/12
Filed: 2004-09-22
Abstract: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.
Patent CA-2540858-A1 (CA)
Inventor: CONDROSKI KEVIN RONALD
IPC: A61K38/00
Filed: 2004-10-13
Abstract: L'invention concerne des composés représentés par les formules générales I à X, ainsi que des compositions, notamment des compositions pharmaceutiques, contenant un desdits composés. L'invention concerne également des méthodes de traitement, notamment des méthodes de traitement de l'infection par le virus de l'hépatite C et de la fibrose du foie. Ces méthodes consistent en général à administrer à un patient une quantité efficace d'un composé ou d'une composition selon l'invention.
Patent CA-2541193-A1 (CA)
Inventor: DAVIES CHRIS M
IPC: H04L12/18
Filed: 2006-03-01
Abstract: This system and method allows the multicasting of user data packets in an ad hoc mesh network.  It makes use of a tree rooted at the sending node and marked paths to that root by nodes wishing to receive the multicast packets.
Patent CA-2541637-A1 (CA)
Title: Pb-free solder alloy compositions comprising essentially tin (sn), silver (ag), copper (cu), phosphorus (p) and rare earth: cerium (ce) or lanthanum (la)
Inventor: LEUNG DAVID D L
IPC: C22C13/00
Filed: 2006-03-13
Abstract: A Pb-free solder alloy is designed from the Sn based substrate, which is a non-toxic and environmental friendly metal. The Pb-free solder includes a composition consisting essentially of 0.3 - 0.4 weight % Ag, 0.6 - 0.7 weight % Cu, 0.01 - 0.3 weight % P, 0.001 - 0.3 weight % Ce, optionally 0.001 - 0.3 weight % La, and a balance of Sn, having off--eutectic melting temperatures of about 217-227 degree Celsius.   0.001 - 0.3 weight % Trace amount of Ce and / or La rare earth added to the said composition, to enhance better micro-structural stability and to reduce the coarse Sn grains in the microstructure of the solder joint formed, during Hand Soldering, Wave Soldering and Reflow Soldering in Electronics Assembly Processes.
Patent CA-2545117-A1 (CA)
Inventor: CAPPS CHARLES L
IPC: C11D1/66
Filed: 2004-11-03
Abstract: This disclosure relates to inventive methods for inactivating viral pathogens in which the steps of the methods in-clude: (a) providing a virucidal composition comprising a liquid media containing less than 1 % weight per volume cetylpyridinium chloride; and (b) contacting the virucidal composition with a surface targeted for disinfection. This disclosure further relates to inventive virucidal compositions, in which the compositions include: (a) a liquid media; (b) cetylpyridinium chloride in solution in the liquid media at a concentration of less than 1 % weight per volume; (c) an extender; and (d) an enhancer.
Patent CA-2549744-A1 (CA)
Title: Systeme pour l'amelioration adaptative de signaux vocaux
Inventor: GIESBRECHT DAVID
IPC: G10L21/02
Filed: 2006-06-09
Abstract: Système pour améliorer la réponse en fréquence de signaux vocaux. Une estimation de la forme spectrale vocale moyenne est calculée au cours d'une période donnée en fonction du signal vocal d'entrée. L'estimation de la forme spectrale vocale moyenne peut être calculée dans le domaine de fréquence au moyen d'un filtre à réponse impulsionnelle infinie de premier ordre ou d'intégrateurs à fuite. Par conséquent, l'estimation de la forme spectrale vocale moyenne s'adapte au fil du temps aux changements des caractéristiques acoustiques du trajet de la voix ou à tout changement du trajet audio électrique pouvant avoir des répercussions sur la réponse en fréquence du système. Un facteur de correction spectrale peut être déterminé en comparant l'estimation de la forme spectrale vocale moyenne à une forme spectrale cible souhaitée. Le facteur de correction spectrale peut être ajouté (en unités de dB) au spectre du signal vocal d'entrée afin d'améliorer ou d'ajuster le spectre du signal vocal d'entrée par rapport à la forme spectrale souhaitée et un signal vocal amélioré peut être synthétisé de nouveau à partir du spectre corrigé.
Patent CA-2551002-A1 (CA)
Title: Compositions durcissables comprenant des groupes du type .beta.-hydroxyamide issus de la reaction de lactones
Inventor: TANG XUN
IPC: D04H1/645
Filed: 2006-06-23
Abstract: La présente invention a pour objet des compositions durcissables comprenant i) un ou plusieurs  polyacides contenant au moins deux groupes carboxyliques, des groupes anhydrides ou des sels de ceux-ci; ii) éventuellement, un ou plusieurs polyols contenant au moins deux groupes hydroxyles; iii) un ou plusieurs polyols contenant un groupe .bêta.-hydroxylamide, qui est le produit de réaction entre une lactone ou un ester cyclique et une alcanolamine, ayant la formule suivante (I): (voir la formule I) dans laquelle R et R" représente de manière indépendante un H ou un radical alkyl monovalent en C1 à C18 linéaire ou ramifié, radical qui peut comprendre un ou deux groupes aryles ou cycloalkyles, un ou plusieurs groupes hydroxyles, amino, thiol, amides, carboxyles or alcényles, ou des combinaisons de ceux-ci; R' représente soit une liaison covalente soit un radical alcylène en C1 à C5 divalent, ce radical alcylène pouvant porter des groupes alkyles; y est égal à 1 ou 2; x est égal à 0 ou 1, de manière à ce que (x + y) = 2; dans lesquelles le rapport entre le nombre d'équivalents desdits groupes acides, desdits groupes anhydrides et des sels de ceux-ci et le nombre d'équivalents desdits groupes hydroxyles va de 1/0,01 à 1/3. Les compositions durcissables de la présente invention fournissent des liants moins corrosifs et à faible énergie de durcissement. De plus, on divulgue dans la présente invention des méthodes pour utiliser ces compositions comme liants aqueux pour des substrats composites, non tissés et tissés, ainsi que les produits ainsi obtenus.
Patent CA-2551616-A1 (CA)
Title: A process for the purification of imiquimod
Inventor: MAGRONE DOMENICO
IPC: C07B63/00
Filed: 2006-07-07
Abstract: Crystalline forms of imiquimod, a process for the preparation thereof and the use thereof in the purification of imiquimod.
Patent CA-2551878-A1 (CA)
Inventor: GRAH MICHAEL D
IPC: C08K7/24
Filed: 2004-12-29
Abstract: A method of shrinking a film comprises the steps of providing a shrink film and exposing the film to an amount of radiation energy effective to activate the shrink characteristic of the film. The film comprises one or more thermoplastic polymers and at least about 0.001 weight % of single-walled carbon nanotube material based on the weight of the film.
Patent CA-2552394-A1 (CA)
Inventor: AISSA SAMI
IPC: H03L7/191
Filed: 2004-12-15
Abstract: An oscillator (30) supplies a high frequency signal (S) to a frequency divider (31) . A phase comparator (32) produces a signal measuring phase difference between the divided frequency signal (QA) and a reference signal. A low-pass filter (34) controls the oscillator on the basis of the measurement signal. A  measurement window, of duration defined by counting cycles of the high frequency signal, is generated in response to each active edge of the divided frequency signal. The measurement signal is activated during the measurement window so that it comprises, when an active edge of the reference signal falls within the window, a first pulse between the start of the window and this edge and a second pulse, opposite to the first, between this edge and the end of the window.
Patent CA-2553840-A1 (CA)
Title: Amino alcohol derivatives and their activity as renin inhibitors
Inventor: STUTZ STEFAN
IPC: C07C311/13
Filed: 2005-01-21
Abstract: The application relates to novel amino alcohols of general formula (I) where R, R1, R2, R3, R4, R5,X1 and X2 each have the definitions illustrated in detail in the description, to a process for their preparation and to the use of these compounds as medicines, in particular as renin inhibitors.
Patent CA-2554899-A1 (CA)
Inventor: DUPONT GINETTE
IPC: G01N33/573
Filed: 2005-02-07
Abstract: The present invention is related to accurate detection methods for the measurement only of myeloperoxidase (MPO) levels of neutrophils, preferably equine neutrophils, in complex biological samples. The present invention is further related to ELISA and SIEFED assays for such detection. SIEFED  detection sensitivity of active peroxidase activity was found to be enhanced by the addition of nitrite. Such MPO measurement finds its use in many applications such as the prediction, diagnosis and/or monitoring of pathologies correlated with neutrophil activation and/or destruction; the evaluation of drugs and/or immunomodulators; the assessment of immune responses, either natural and/or after treatment with immunomodulators and/or drugs; and the study of cells and their ability to fight microorganisms and/or to destroy them.